Apply for a trade account

Orforglipron wholesale specification sheet

Short answerOrforglipron wholesale supply from International Wholesale Peptides is research-grade only. It is supplied as tablets, catalogue strength 6 mg per tablet, to verified research institutions, with a certificate of analysis for every lot that names the testing laboratory. For research use only. Not for human or veterinary use.

Updated · 3 min read

Specification sheet

Compound
Orforglipron
Synonyms
LY3502970
Class
Synthetic non-peptide small molecule (not a peptide)
Molecular formula
C48H48F2N10O5
Molecular weight
883.0 g/mol
CAS number
2212020-52-3
Supplied form
Compressed tablets in bottles (research-grade)
Purity specification
Assay and purity stated on the certificate
Storage (stock)
Per certificate; sealed original bottle, dry, protected from light
Origin statement
Stated on the quote and on every lot
Buyer classes
Verified research institutions

Orforglipron is a synthetic small molecule. It is not a peptide: it contains no amino acid chain, and it is listed here because it belongs to the same catalogue category as the GLP research compounds. Its molecular formula is C48H48F2N10O5 and its molecular weight is 883.0 g/mol. This sheet covers Orforglipron wholesale supply for verified research institutions: identity, supplied forms, lot documents, stock storage, regulatory status and ordering terms.

Identity and specification

Item Specification
Name Orforglipron
Synonyms LY3502970
Class Synthetic non-peptide small molecule (not a peptide)
Sequence Not applicable (not a peptide)
Molecular formula C48H48F2N10O5
Molecular weight 883.0 g/mol
CAS number 2212020-52-3
Appearance Compressed tablet; description stated on the certificate
Salt or solid form Stated on certificate

The values are for the free form. Because orforglipron is a small molecule, the certificate of analysis reports assay in place of peptide content and identifies the compound by a method named on the certificate. The salt or solid form of a lot is stated on the certificate.

Supplied forms and catalogue strengths

Form Catalogue strength Pack
Research-grade tablets 6 mg per tablet Bottle of 90 tablets

Orforglipron is listed in the GLP Research Compounds category and is supplied as research-grade tablets, described on the oral tablets format page. It is not supplied in vials.

For research use only. Not for human or veterinary use. Orforglipron is sold only to verified research institutions. The strengths above state the content of one tablet as a pack description for purchasing and stock control. This sheet gives no preparation or use information.

Testing and documents per lot

Each lot ships with a certificate of analysis that names the testing laboratory. It identifies the compound and reports assay, and the tests reported for the tablet format are listed on the quote. The fields are explained on the certificate of analysis page, and a lot number can be checked with the lot lookup.

Storage and handling for stock

Hold Orforglipron tablets in the sealed original bottle, in the condition printed on the certificate for the lot. Keep the bottles dry and protected from light, and keep each bottle sealed until it is issued to the laboratory.

The retest or expiry date is printed on the certificate. Shipping conditions are stated on the quote and the packing list. Record the receiving temperature and rotate stock by lot number. The peptide storage and cold chain guide covers warehouse practice in more detail. This sheet gives stock-holding conditions only.

Regulatory status

As of November 2026, orforglipron is the active ingredient of an FDA-approved prescription medicine. FDA announced the approval on 1 April 2026 in a press announcement. The approval covers the finished medicine of its marketing authorization holder. It does not cover research-grade material, and the material on this sheet is not that medicine. This sheet describes chemical identity only. Orforglipron is a prescription-only substance when it is presented for human use. Status outside the United States differs by country, and buyers must confirm it in their own market with their regulator or counsel.

IWP supplies Orforglipron only as research-grade material to verified research institutions. For research use only. Not for human or veterinary use. The research-use-only label describes the intended use of the goods in a laboratory. It is not a route around a medicine rule, and IWP declines an order where the stated use, the buyer or the quantities point to use in people or animals. A medicine reaches human use only through the licensed medicine supply chain of the country concerned, which is a separate route from this catalogue.

Ordering Orforglipron wholesale

Ordering follows one sequence: application, verification as a research institution, quote, order. The quote names the origin statement of the lot and the pack. IWP ships only where a lawful route exists for the product and the buyer, and confirms that route in writing before taking an order. Minimums and volume breaks are in the trade terms. Accounts are opened through the application page.

Frequently asked questions

What strengths of Orforglipron are in the catalogue?

Orforglipron is listed as research-grade tablets at 6 mg per tablet, bottle of 90. Case quantities, price breaks, minimums and lead times for the tablet format are stated on the quote after verification, which also names the origin statement of the lot.

What is the regulatory status of Orforglipron?

As of November 2026, orforglipron is the active ingredient of an FDA-approved prescription medicine. FDA announced the approval on 1 April 2026. This sheet describes chemical identity only. IWP supplies orforglipron only as research-grade material to verified research institutions, and not for use in people or animals.

Is orforglipron a peptide?

No. Orforglipron is a synthetic non-peptide small molecule, formula C48H48F2N10O5 and molecular weight 883.0 g/mol. It is filed in the GLP Research Compounds category by catalogue class, not by chemistry. The certificate of analysis reports assay and identity in place of peptide content.

Who can buy Orforglipron wholesale?

Verified research institutions only. The institution documents its research activity, the responsible person and the laboratory address during verification. IWP does not sell Orforglipron to individuals, and it is not supplied to any buyer for human or veterinary use. A lawful route is confirmed in writing before an order.

What documents ship with a Orforglipron lot?

A certificate of analysis that names the testing laboratory and identifies the compound in the lot. It reports assay and the tests listed on the quote for the tablet format. The lot number on the label can be checked against its certificate on the lot lookup page.

Open a trade account

Tell us what you buy and where you ship. We verify your business, confirm the lawful route in writing and send a quote.

Apply for a trade account